Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H13N3O4 |
Molecular Weight | 239.2279 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)C2=C
InChI
InChIKey=PULHLIOPJXPGJN-BWVDBABLSA-N
InChI=1S/C10H13N3O4/c1-5-8(15)6(4-14)17-9(5)13-3-2-7(11)12-10(13)16/h2-3,6,8-9,14-15H,1,4H2,(H2,11,12,16)/t6-,8+,9-/m1/s1
Molecular Formula | C10H13N3O4 |
Molecular Weight | 239.2279 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Model of chemotherapy-induced myelosuppression with parameter consistency across drugs. | 2002 Dec 15 |
|
Design and synthesis of novel prodrugs of 2'-deoxy-2'-methylidenecytidine activated by membrane dipeptidase overexpressed in tumor tissues. | 2007 Apr 15 |
|
Effect of dose regimen on the toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC) in monkeys. | 2007 Oct |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:40:59 GMT 2023
by
admin
on
Sat Dec 16 09:40:59 GMT 2023
|
Record UNII |
FLT15E4X9N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID60923120
Created by
admin on Sat Dec 16 09:40:59 GMT 2023 , Edited by admin on Sat Dec 16 09:40:59 GMT 2023
|
PRIMARY | |||
|
3005913
Created by
admin on Sat Dec 16 09:40:59 GMT 2023 , Edited by admin on Sat Dec 16 09:40:59 GMT 2023
|
PRIMARY | |||
|
FLT15E4X9N
Created by
admin on Sat Dec 16 09:40:59 GMT 2023 , Edited by admin on Sat Dec 16 09:40:59 GMT 2023
|
PRIMARY | |||
|
119804-96-5
Created by
admin on Sat Dec 16 09:40:59 GMT 2023 , Edited by admin on Sat Dec 16 09:40:59 GMT 2023
|
PRIMARY |